Q-omics provides the consensus-scored SNORD115-13 profile across patient tissues and cancer cell-line models. Additionally, SNORD115-13 mutation status shows 11 significant gene co-expression associations, with the highest sampling consensus in LUSC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SNORD115-13 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SNORD115-13 in patient tissues and cancer cell lines. In patient samples, SNORD115-13 shows the broadest associations at the RNA and protein expression levels, with LUSC recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼Mutation
RNA	11	LUSC (6)	view →
Infiltrating cells	1	LUSC (1)	view →